Start for free
Start for free
NS Investment logo

NS Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company.

Investor Profile

NS Investment has made 19 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (53%)
  • Series C (32%)
  • Series F (5%)
  • Series A (5%)
  • Series Unknown (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Genetics
  • Oncology
  • Emergency Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NS Investment frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 6
OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 7
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 7
Hillhouse Investment
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 4
ArrowMark Partners
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 3
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 4
The Column Group
The Column Group
North America, California, United States, San Francisco
Co-Investments: 5
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 4

What are some of recent deals done by NS Investment?

Accent Therapeutics

Lexington, Massachusetts, United States

Accent Therapeutics is a biopharmaceutical company.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CJan 23, 2024
Amount Raised: $75,000,000
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series AAug 25, 2022
Amount Raised: $84,000,000
Aspen Neuroscience

San Diego, California, United States

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BMay 9, 2022
Amount Raised: $147,500,000
Dewpoint Therapeutics

Boston, Massachusetts, United States

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CFeb 3, 2022
Amount Raised: $150,000,000
Maze Therapeutics

South San Francisco, California, United States

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

BiotechnologyTherapeutics
Series UnknownJan 10, 2022
Amount Raised: $190,000,000
Shoreline Biosciences

La Jolla, California, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

BiotechnologyHealth CareLife ScienceMedical
Series BNov 2, 2021
Amount Raised: $140,000,000
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceutical
Series BOct 21, 2021
Amount Raised: $80,000,000
Immunitas Therapeutics

Cambridge, Massachusetts, United States

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series BAug 18, 2021
Amount Raised: $58,000,000
Sonoma BioTherapeutics

South San Francisco, California, United States

Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.

BiotechnologyLife ScienceTherapeutics
Series BAug 4, 2021
Amount Raised: $265,000,000
Accent Therapeutics

Lexington, Massachusetts, United States

Accent Therapeutics is a biopharmaceutical company.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BApr 23, 2020
Amount Raised: $63,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator